Asian Countries Turn to Other Vaccines, Are Sinovac and Sinopharm Fading Effectiveness?

Across Asia, Chinese-made vaccines have played an important role in immunization efforts against Covid-19, with millions receiving injections of Sinovac or Sinopharm. But in recent weeks, there has been growing concern about its efficacy. Currently, several Asian countries that make vaccines made in China as an important component in immunization programs have announced that they will use other vaccines.

This move raises questions, not only about whether China's vaccines can be trusted, but also about vaccine diplomacy efforts in Asia. Last week, Thailand announced it would change its vaccine policy. Instead of receiving two Sinovac injections, citizens will now receive a mixture of Sinovac and AstraZeneca vaccines. Health workers who have been fully vaccinated with Sinovac will also receive a different injection as a booster injection. Indonesia had announced a similar move the previous week, saying it was giving a Moderna booster shot to healthcare workers immunized with Sinovac.

|•SOURCE•| Articles :KOMPAS | Image :WHO |

READ MORE

|• NATIONAL •|Tjiwi Kimia Wins covid 19 Prevention
|• INTERNATIONAL •|Sultan of Gunung Tabur Berau Coal
|• BANKING •|Fiscal Reform Becomes Valuable Capital
|• POLITICS •|Bank Mandiri and SUN Energy Sign MoU
|• BUSINESS •|Inspection Ensure Cooking Oil Supply